Adar1 Capital Management, LLC Glycomimetics Inc Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 331,827 shares of GLYC stock, worth $86,275. This represents 0.02% of its overall portfolio holdings.
Number of Shares
331,827
Previous 45,700
626.1%
Holding current value
$86,275
Previous $7.72 Million
969.86%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GLYC
# of Institutions
37Shares Held
27.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.48 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.4 Million0.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.32 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$780,0000.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$694,2540.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $13.6M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...